EXACT Therapeutics AS (FRA:56F)

Market Cap	9.58M -53.2%
Revenue (ttm)	n/a
Net Income	-6.08M
EPS	-0.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1110
Previous Close	0.1110
Day's Range	0.1110 - 0.1110
52-Week Range	0.0685 - 0.2960
Beta	n/a
RSI	42.39
Earnings Date	Apr 8, 2026

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Employees: 12
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 56F

Financial Performance

Financial numbers in NOK